CYP19A1 and polycystic ovary syndrome: Disruption of aromatase function can lead to elevated or reduced levels of androgens or estrogen, which are associated with a wide variety of common pathologies (endometriosis, osteoporosis, hypogonadism, Alzheimer’s disease, cancer, and PCOS) [201].